<DOC>
	<DOCNO>NCT00897039</DOCNO>
	<brief_summary>RATIONALE : Collecting sample tissue patient cancer study laboratory may help doctor predict well patient respond treatment certain chemotherapy drug plan best treatment . PURPOSE : This laboratory study look tumor tissue sample predict response chemotherapy patient ovarian cancer , fallopian tube cancer , primary peritoneal cancer .</brief_summary>
	<brief_title>Laboratory Study Predicting Tumor Response Chemotherapy Patients With Ovarian Cancer , Fallopian Tube Cancer , Primary Peritoneal Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Evaluate ability microculture kinetic ( MiCK ) assay predict outcome patient ovarian , fallopian tube , primary peritoneal adenocarcinoma treat first-line chemotherapy . - Evaluate ability MiCK assay guide chemotherapy third-line , refractory treatment setting ( exclusive anti-vascular endothelial growth factor ) patient . OUTLINE : Patients stratify accord prior chemotherapy ( [ stratum I ] vs yes [ stratum II ] ) . Tumor tissue and/or effusion specimen collect baseline . Specimens examine microculture kinetic ( MiCK ) assay immunocytochemical flow cytometry assay . MiCK assay result influence treatment stratum I patient . Stratum II patient may receive treatment base MiCK assay result tumor sensitivity specific chemotherapy drug . PROJECTED ACCRUAL : A total 60 patient accrue study .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<mesh_term>Peritoneal Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Pathologically confirm adenocarcinoma 1 follow type : Ovarian Primary peritoneal Fallopian tube Must meet 1 follow criterion : De novo malignancy prior chemotherapy Advanced refractory malignancy â‰¤ 2 standard chemotherapy treatment protocols Tumor must accessible biopsy drainage effusion Chemotherapy consider treatment option No symptomatic uncontrolled parenchymal brain metastases No meningeal metastasis PATIENT CHARACTERISTICS : Not pregnant Negative pregnancy test Fertile patient must agree use effective contraception PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>ovarian serous cystadenocarcinoma</keyword>
	<keyword>ovarian undifferentiated adenocarcinoma</keyword>
	<keyword>recurrent ovarian epithelial cancer</keyword>
	<keyword>ovarian clear cell cystadenocarcinoma</keyword>
	<keyword>ovarian endometrioid adenocarcinoma</keyword>
	<keyword>ovarian mucinous cystadenocarcinoma</keyword>
	<keyword>stage IA ovarian epithelial cancer</keyword>
	<keyword>stage IB ovarian epithelial cancer</keyword>
	<keyword>stage IC ovarian epithelial cancer</keyword>
	<keyword>stage IIA ovarian epithelial cancer</keyword>
	<keyword>stage IIB ovarian epithelial cancer</keyword>
	<keyword>stage IIC ovarian epithelial cancer</keyword>
	<keyword>stage IIIA ovarian epithelial cancer</keyword>
	<keyword>stage IIIB ovarian epithelial cancer</keyword>
	<keyword>stage IIIC ovarian epithelial cancer</keyword>
	<keyword>recurrent primary peritoneal cavity cancer</keyword>
	<keyword>stage IA primary peritoneal cavity cancer</keyword>
	<keyword>stage IB primary peritoneal cavity cancer</keyword>
	<keyword>stage IC primary peritoneal cavity cancer</keyword>
	<keyword>stage IIA primary peritoneal cavity cancer</keyword>
	<keyword>stage IIB primary peritoneal cavity cancer</keyword>
	<keyword>stage IIC primary peritoneal cavity cancer</keyword>
	<keyword>stage IIIA primary peritoneal cavity cancer</keyword>
	<keyword>stage IIIB primary peritoneal cavity cancer</keyword>
	<keyword>stage IIIC primary peritoneal cavity cancer</keyword>
	<keyword>recurrent fallopian tube cancer</keyword>
	<keyword>stage IA fallopian tube cancer</keyword>
	<keyword>stage IB fallopian tube cancer</keyword>
	<keyword>stage IC fallopian tube cancer</keyword>
	<keyword>stage IIA fallopian tube cancer</keyword>
	<keyword>stage IIB fallopian tube cancer</keyword>
	<keyword>stage IIC fallopian tube cancer</keyword>
	<keyword>stage IIIA fallopian tube cancer</keyword>
	<keyword>stage IIIB fallopian tube cancer</keyword>
	<keyword>stage IIIC fallopian tube cancer</keyword>
</DOC>